acetazolamide Tablets, immediate release (IR) 250 mg
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
MHRA
Available for
Distribution only
Manufacturer #19523
A UK-based pharmaceutical manufacturer specialising in generic medicines and supplying a wide range of pharmaceutical products to healthcare providers and distributors. The company focuses on developing, manufacturing and distributing affordable generic pharmaceutical products in multiple dosage forms, supported by GMP-compliant facilities and regulatory approvals required for the national market. It emphasizes strong quality-control systems, consistent manufacturing standards and reliable supply to ensure safe and effective pharmaceutical products for patients and healthcare professionals.
Acetazolamide is a medication used to treat glaucoma, epilepsy, edema, altitude sickness, hydrocephalus, and hypokalemic periodic paralysis. Suppliers of acetazolamide market it in the form of 250mg and 500mg tablets as well as 500mg powders for an injectable solution.
In use for over 50 years, the drug has since become included in the World Health Organization’s List of Essential Medicines that contain the most important drugs recommended for a basic Health System. There are numerous acetazolamide manufacturers and distributors, with the largest globally being companies Teva, TARO, Zydus Pharmaceuticals, and Lannett.
Acetazolamide suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified acetazolamide manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 20 (250mg) tablets of acetazolamide fall into a range of approximately 4,00 EUR to 5,00 EUR.